EVP, Chief Financial Officer
Thu, Jul 2, 2026
13d ago
4,677 shares @ $18.00
Decreased holdings by -2.90%
9th largest trade (out of 35)
Positive 90D History
Trade made by an officer
10b5-1 scheduled trade
72% win rate · +18.6% median edge vs SPY (18 trades, 90-day · small sample)
Price 28% above 200-day moving average
NTLAIntellia Therapeutics, Inc.
Health CareDiagnostics & Research
1D0.00%
1W-21.08%
1M-10.92%
3M-6.14%
6M—
1Y—